Dr AlBastaki is the Head of Drug Registration Department and the acting Drug Laboratory Superintendent in Pharmaceutical and Herbal Medicines Registration and Control Administration, Ministry of Health. She has a twenty years working experience in the pharmaceutical field; area of expertise are regulatory affairs and pharmacovigilance.
She Contributed to the development of drug regulatory framework and policies in Kuwait and GCC.
She is responsible of registration and approval of a various pharmaceutical and health products, in addition to laboratory analysis of medical products, and monitoring post marketing drugs safety and efficacy.
She has a 17 years’ experience in GMP inspection through which she inspected several international, regional and local pharmaceutical manufacturing companies.
She is a Former Member of Gulf Health Council Central Drug Registration Committee and contributed to setting the GCC Guidelines for Drug Registration as well as Stability, Bioequivalence and PIL GCC guidelines and others.
She’s a member of the International Society of Pharmacovigilance and Kuwait deputy focal point for Uppsala Monitoring Center /WHO Collaborating Center for International Drug Monitoring.
She was also assigned as Kuwait focal point with the League of Arab states in the field of Pharmacy and drugs and participated in the development of the Arab Bioequivalence Guidelines.